David A. Copland
- Ophthalmology top 0.5%
- Immunology top 5%
- Molecular Biology
- Neurology top 5%
- Rheumatology top 5%
- Co-authors
- Andrew D. DickLindsay B. NicholsonBen J. E. RaveneyJian LiuSofia TheodoropoulouKeng Siang LeeHeping XuJiahui Wu
- Topics
- Ocular Diseases and Behçet’s Syndrome (15 papers)Neuroinflammation and Neurodegeneration Mechanisms (12 papers)Retinal Diseases and Treatments (11 papers)
- Cited by
- OphthalmologyNeurologyImmunology
- Journals
- The LancetSHILAP Revista de lepidopterologíaThe Journal of Immunology
- Partner nations
- United KingdomGermanyUnited States
In The Last Decade
David A. Copland
53 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 92
- Ophthalmology 858
- Immunology 562
- Molecular Biology 451
- Neurology 287
- Rheumatology 193
Countries citing papers authored by David A. Copland
This map shows the geographic impact of David A. Copland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David A. Copland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David A. Copland more than expected).
Fields of papers citing papers by David A. Copland
This network shows the impact of papers produced by David A. Copland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David A. Copland. The network helps show where David A. Copland may publish in the future.
Co-authorship network of co-authors of David A. Copland
This figure shows the co-authorship network connecting the top 25 collaborators of David A. Copland. A scholar is included among the top collaborators of David A. Copland based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David A. Copland. David A. Copland is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 6 | |
| 3 | 8 | |
| 4 | 8 | |
| 5 | 104 | |
| 6 | 15 | |
| 7 | Gene therapy for Glaucoma by CRISPR-Cas9 mediated disruption of Aquaporin 1 in the Ciliary Body | 1 |
| 8 | 12 | |
| 9 | 72 | |
| 10 | 9 | |
| 11 | 32 | |
| 12 | 9 | |
| 13 | 8 | |
| 14 | 3 | |
| 15 | CD200 Receptor signaling subverts pro-angiogenic macrophage phenotype generation and experimental chorioretinal neovascularisation | 1 |
| 16 | 76 | |
| 17 | Local Anti-C5 Therapy Suppresses Experimental Choroidal Neovascularization Through Reduction Of Macrophage Infiltrate | 2 |
| 18 | 50 | |
| 19 | 45 | |
| 20 | 136 |
About David A. Copland
David A. Copland is a scholar working on Ophthalmology, Neurology and Immunology, having authored 54 papers that have together received 1.5k indexed citations. Recurring topics across this work include Ocular Diseases and Behçet’s Syndrome (15 papers), Neuroinflammation and Neurodegeneration Mechanisms (12 papers) and Retinal Diseases and Treatments (11 papers). The work is most often cited by research in Ophthalmology (858 citations), Neurology (287 citations) and Immunology (562 citations). David A. Copland has collaborated with scholars based in United Kingdom, Germany and United States. Frequent co-authors include Andrew D. Dick, Lindsay B. Nicholson, Ben J. E. Raveney, Jian Liu, Sofia Theodoropoulou, Keng Siang Lee, Heping Xu, Jiahui Wu, Colin J. Chu and Claudia J. Calder. Their work appears in journals such as The Lancet, SHILAP Revista de lepidopterología and The Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.